ArticleEuropean journal of nuclear medicine and molecular imaging2021

Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging.

Fabio Minutoli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.